30.11.2010
- Britain's GlaxoSmithKline and Moscow-based Binnopharm have agreed a deal allowing the Russian firm to make GSK's cervical cancer, rotavirus and pneumococcal vaccines for the...
14.09.2010
- What do you consider to be the biggest trends in custom manufacturing? J. Decker-Conradi (Bayer Healthcare): We at Bayer HealthCare (BHC) look for suppliers which are reliable and...
14.09.2010
- The name of the game is focusing on core competencies - and this is something custom manufacturers have been able to benefit from over the last several years. This trend has set...
03.09.2010
- Drugmaker Abbott Laboratories has decided against the sale of its European flu-vaccine business after initial bids came in below its expectations, a company spokeswoman confirmed...
30.08.2010
- Lonza enters the viral based-manufacturing market today with its purchase of Vivante GMP Solutions. The acquisition advances Lonza's strategy to broaden its biologics custom...
19.08.2010
- The U.S. government proposed big changes on Thursday to the way it works with companies to fight new disease threats such as flu, including reform at the Food and Drug...
30.06.2010
- Abbott Laboratories is exploring the sale of its flu vaccine unit acquired as part of its purchase of Solvay's drugs unit. "Abbott is exploring the option to potentially sell the...
31.05.2010
- Pfizer, the world's biggest drugmaker, is selling its swine vaccine business in China to Harbin Pharmaceutical Group for $50 million, a source with direct knowledge of the deal...
